FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

4465511000001104: Mitoxantrone 20mg/10ml solution for injection vials (Mayne Pharma Plc) 1 vial (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
26450501000001114 Mitoxantrone 20mg/10ml solution for injection vials (Mayne Pharma Plc) 1 vial (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
106082701000001110 Mitoxantrone 20mg/10ml concentrate for solution for infusion vials (Pfizer Ltd) 1 vial en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mitoxantrone 20mg/10ml solution for injection vials (Mayne Pharma Plc) 1 vial Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Mitoxantrone 20mg/10ml solution for injection vials (Mayne Pharma Plc) 1 vial Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Mitoxantrone 20mg/10ml solution for injection vials (Mayne Pharma Plc) 1 vial Is a Mitoxantrone 20mg/10ml solution for injection vials 1 vial true Inferred relationship Existential restriction modifier
Mitoxantrone 20mg/10ml solution for injection vials (Mayne Pharma Plc) 1 vial Is pack of Mitoxantrone 20mg/10ml solution for injection vials (Mayne Pharma Plc) false Inferred relationship Existential restriction modifier
Mitoxantrone 20mg/10ml solution for injection vials (Mayne Pharma Plc) 1 vial Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Mitoxantrone 20mg/10ml solution for injection vials (Mayne Pharma Plc) 1 vial Has active ingredient Mitoxantrone hydrochloride false Inferred relationship Existential restriction modifier
Mitoxantrone 20mg/10ml solution for injection vials (Mayne Pharma Plc) 1 vial Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Mitoxantrone 20mg/10ml solution for injection vials (Mayne Pharma Plc) 1 vial Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Mitoxantrone 20mg/10ml solution for injection vials (Mayne Pharma Plc) 1 vial Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Mitoxantrone 20mg/10ml solution for injection vials (Mayne Pharma Plc) 1 vial VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Mitoxantrone 20mg/10ml solution for injection vials (Mayne Pharma Plc) 1 vial VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Mitoxantrone 20mg/10ml solution for injection vials (Mayne Pharma Plc) 1 vial Has manufactured dose form Conventional release solution for injection false Inferred relationship Existential restriction modifier
Mitoxantrone 20mg/10ml solution for injection vials (Mayne Pharma Plc) 1 vial Has AMP Mitoxantrone 20mg/10ml solution for injection vials (Mayne Pharma Plc) true Inferred relationship Existential restriction modifier
Mitoxantrone 20mg/10ml solution for injection vials (Mayne Pharma Plc) 1 vial Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Mitoxantrone true Inferred relationship Existential restriction modifier
Mitoxantrone 20mg/10ml solution for injection vials (Mayne Pharma Plc) 1 vial Has specific active ingredient Mitoxantrone hydrochloride true Inferred relationship Existential restriction modifier
Mitoxantrone 20mg/10ml solution for injection vials (Mayne Pharma Plc) 1 vial Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Mitoxantrone 20mg/10ml solution for injection vials (Mayne Pharma Plc) 1 vial Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Mitoxantrone 20mg/10ml solution for injection vials (Mayne Pharma Plc) 1 vial Has basis of strength substance Mitoxantrone true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start